Latest News

Key Insights Bird Construction's estimated fair value is CA$56.89 based on 2 Stage Free Cash Flow to Equity Current...

Inventronics (CVE:IVX) has had a great run on the share market with its stock up by a significant 20% over the last...

If you have been watching UGI recently, you have probably noticed its share price has been anything but boring. After a year marked by steady momentum, UGI’s stock is up a whopping 43.3% over the past twelve months. That includes a 19.2% gain year-to-date, so it is no surprise that investors are wondering if there is still room for the stock to run or if it is time to tread cautiously. Much of this optimism seems to be driven by the company’s ongoing strategic initiatives, like the steady...

When close to half the companies in Canada have price-to-earnings ratios (or "P/E's") below 16x, you may consider...

Procter & Gamble (PG) reported annual earnings growth of 7.5% this year, up from a 2.2% average over the last five years. Net profit margins also improved, rising to 18.6% from 17.4%. With revenue and earnings growth forecasts pointing to 3% per year, trailing the broader US market’s expectations, investors will note the recent boost in profitability. However, they will need to assess it against simmering concerns around the company's moderate growth profile and risks like insider selling and...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights The projected fair value for Lear is US$143 based on 2 Stage Free Cash Flow to Equity Lear is estimated to...

With a median price-to-earnings (or "P/E") ratio of close to 19x in the United States, you could be forgiven for...

If you’re eyeing Bank of China right now, you’re not alone. With sizable moves in its share price lately and some headlines stirring up investor sentiment, it’s a stock worth a closer look. Over the past week, Bank of China’s shares have crept up 2.6%, contributing to a sturdy 23.8% climb over the last year and an impressive 163.2% surge in the past five years. Those kinds of returns don’t just happen by accident. Clearly, something is shifting in how investors perceive the risks and...

Aptera Motors has officially transitioned to a Public Benefit Corporation. This move ties its governance to sustainability goals in solar electric vehicle development. The company also strengthened its Board by appointing two industry veterans. See our latest analysis for Aptera Motors. Aptera’s latest flurry of leadership changes, index inclusion, and new share filings has certainly kept it in the headlines, and the stock has responded in kind. After surging over 50% in the past week,...

Medistim (OB:MEDI) reported ongoing momentum in both revenue and earnings, with annual earnings growth forecast at 8.55% and revenue anticipated to rise by 7.5% per year. Net profit margins were up to 20.9%, compared to 19.6% a year ago, and recent earnings growth hit 25.7%, comfortably above the five-year average of 10% per year. Investors are likely to see these results as signs of operational strength, even as share price stability has been lacking over the past three months and valuation...

PCB Bancorp (PCB) reported a net profit margin of 30%, up from 25.3% the prior year, with earnings growing 29.4% year-over-year. This is well above its five-year average annual rate of 1.4%. The stock trades at a Price-to-Earnings Ratio of 9.9x, lower than both the peer average of 12.2x and the US Banks industry average of 11.2x. The share price of $21.48 is below an estimated fair value of $31.14 based on discounted cash flow analysis. With solid profitability, discounted market multiples,...

Shore Bancshares (SHBI) posted net profit margins of 26.8%, up from last year’s 21.3%, with earnings growth of 38.5% over the past year. This performance is well ahead of its five-year average of 26% per year. With a Price-to-Earnings Ratio of just 9.3x, notably lower than both peer and US bank industry averages, and dividends that remain attractive, the company’s results highlight continued profit and revenue growth for investors. However, forecasts show earnings growth slowing to 5.8%...

Kemira Oyj (HLSE:KEMIRA) reported a robust 25.2% increase in earnings over the past year, topping its five-year average annual growth of 15.5%. Net profit margins expanded to 7.9% from 5.7%, and the company is maintaining high quality earnings with no significant risks called out by the latest data. Investors are watching as Kemira’s steady margin improvement and attractive valuation could drive sentiment, even as future earnings and revenue growth are forecast to trail wider market...

Quantum (QMCO) is making headlines after revealing major accounting issues that have led to the need for restating previous financial statements. These developments, which include the CEO's resignation, have sparked multiple class action lawsuits and weighed on investor confidence. See our latest analysis for Quantum. With Quantum under the microscope after its accounting revelations and CEO exit, the share price has staged a modest rebound in the past 90 days, returning nearly 18%. However,...

Key Insights Using the 2 Stage Free Cash Flow to Equity, THG fair value estimate is UK£0.75 THG is estimated to be 36...

Storskogen Group AB (publ)'s ( STO:STOR B ) price-to-sales (or "P/S") ratio of 0.5x may look like a pretty appealing...

Clarkson PLC ( LON:CKN ), is not the largest company out there, but it maintained its current share price over the past...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

With a price-to-earnings (or "P/E") ratio of 7x Kumba Iron Ore Limited ( JSE:KIO ) may be sending bullish signals at...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Orexo (OM:ORX) remains unprofitable, with losses increasing at an average rate of 3.7% per year over the past five years. Revenue is forecast to grow by 2.5% annually, trailing behind the broader Swedish market’s 3.9% average growth. While the company’s slower growth and ongoing losses present real challenges for investors, the current Price-To-Sales Ratio of 1.8x stands out as a notable value play within the European pharmaceuticals sector. See our full analysis for Orexo. Next up, we’ll see...

Merkur PrivatBank KgaA (XTRA:MBK) reported a net profit margin of 9.4%, edging up from 9.3% last year, with annual earnings growth of 11.8% far outpacing its five-year annualized rate of 0.9%. While earnings are projected to grow by 9.8% per year going forward, which is below the German market’s expected 16.5%, and revenue is forecast to rise at 3.1% per year compared to the 6% market average, the figures point to improving profitability with some acceleration on recent trends. Investors are...